Anebulo Pharmaceuticals (NASDAQ:ANEB) Posts Earnings Results

Anebulo Pharmaceuticals (NASDAQ:ANEB) issued its quarterly earnings data on Wednesday. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.08, Yahoo Finance reports.

Anebulo Pharmaceuticals Stock Up 0.5 %

ANEB stock traded up $0.01 during midday trading on Friday, reaching $1.97. The stock had a trading volume of 3,260 shares, compared to its average volume of 6,842. The business has a fifty day simple moving average of $2.05 and a two-hundred day simple moving average of $2.35. The firm has a market cap of $51.09 million, a price-to-earnings ratio of -5.30 and a beta of -1.01. Anebulo Pharmaceuticals has a twelve month low of $1.62 and a twelve month high of $3.61.

About Anebulo Pharmaceuticals

Anebulo Pharmaceuticals, Inc, a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI.